Amid all of the volatility, it could be a great time to invest in great ASX shares that could produce good long-term returns.
Below are two of the top picks I’d buy right now.
Sigma Healthcare Ltd (ASX: SIG)
Sigma Healthcare is best known as the owner of three chemist brands – Chemist Warehouse, Amcal and Discount Drug Stores. It’s also one of the largest wholesale suppliers in Australia.
FY26 was a pleasing year of growth for the company with revenue growth of 15.5% to $10.8 billion, normalised EBIT (EBIT explained) growth of 20.6% to $1.09 billion and normalised net profit growth of 22.3% to $732.3 million.
The Chemist Warehouse business is the important driver of the ASX share. During FY26, 24 Australian Chemist Warehouse-branded stores were added, taking the total to 561.
Despite the impressive level of network expansion, the existing store network is delivering strong double-digit growth. Chemist Warehouse branded retail network like for like (LFL) sales grew 13.4% in FY26.
The company is looking to reinvigorate the Amcal and Discount Drug Store brands.
The ASX share is also expanding overseas, which could drive significant value in the coming years. International store sales grew 23.3% to $1.6 billion, with 20 international stores opened during FY26 – the network reached 98 and international stores grew LFL sales by 12.2%. International EBIT soared 91.3% to $55.8 million.
With an expanding store network in Australia, New Zealand, Ireland and potentially the UK, the future looks bright.
In the first half of FY27, it expects to open 13 new Chemist Warehouses, 27 Amcal stores and 15 Discount Drug Stores. It also expects to add 19 international stores, including first entry into the UK.
I think this ASX share is one to watch.
VanEck MSCI International Quality ETF (ASX: QUAL)
ASX exchange-traded funds (ETFs) can be some of the best investments that Australians can make because of how they can provide diversification and give exposure to great businesses that we simply can’t find on the ASX.
The idea of this fund is to give exposure to the world’s highest-quality companies based on key fundamentals including a high return on equity (ROE), earnings stability and low financial leverage.
When you combine strong and stable profits, as well as a good balance sheet, I think you’re much more likely to see outperformance over the long-term
Currently, some of the largest positions in the portfolio includes Microsoft, Apple, Nvidia, Meta Platforms, Broadcom, Eli Lilly and Visa.
Over the past three years, its portfolio has delivered a net return per year of 14.8%, which I think is solid considering it’s a global portfolio (not just the US) of approximately 300 names.
The QUAL ETF has drifted lower since mid-August, making the portfolio of shares a better value buy today, in my view.
